Clinical implications of herpesvirus infections in patients with AIDS. Introduction.
Masur
H
H
National Institutes of Health, Bethesda, Maryland 20892.
D000163:Acquired Immunodeficiency Syndrome / Q000150:complications*; D000998:Antiviral Agents / Q000627:therapeutic use; D003586:Cytomegalovirus Infections / Q000150:complications; D015828:Eye Infections, Viral / Q000209:etiology; D017245:Foscarnet; D006561:Herpes Simplex / Q000150:complications; D006562:Herpes Zoster / Q000150:complications; D006566:Herpesviridae Infections / Q000150:complications*; D006801:Humans; D010746:Phosphonoacetic Acid / Q000031:analogs & derivatives / Q000627:therapeutic use; D012173:Retinitis / Q000209:etiology
D000998:Antiviral Agents; D017245:Foscarnet; D010746:Phosphonoacetic Acid